Home > Products > For the United States
Propafenone Hydrochloride Extended-Release Capsules, USP
- Route
- Oral
- Dosage form
- Extended Release Capsules
- Strength
- 225mg, 325mg, 425mg
- Rx/OTC
- Rx
- Indication
- Indicated to prolong the time to recurrence of symptomatic atrial fibrillation (AF) in patients with episodic (most likely paroxysmal or persistent) AF who do not have structural heart disease.
- TE Rating
- AB
- Reference Listed Drug
- Rythmol SR®
- ANDA#
- 212928
| Strength |
Form |
Product Description |
Imprint |
Image |
How Supplied |
NDC Number |
HDMA
Sheets |
PI |
SDS |
| 225mg |
Extended Release |
Hard gelatin capsules, No. 1, white opaque cap with white opaque body, the cap is printed with “TWi TO85 225 ” in red ink, containing white to off-white cylindrical-shaped microtablets. |
TWi TO85 225 |
 |
Bottle of 60 |
24979-085-04 |
 |
|
|
| 325mg |
Extended Release |
Hard gelatin capsules, No. 0, white opaque cap with white opaque body, the cap is printed with “TWi TO86 325 ” in red ink, and body is printed with one red band around 3/4 of the circumference of the body, containing white to off-white cylindrical-shaped microtablets. |
TWi TO86 325 |
 |
Bottle of 60 |
24979-086-04 |
|
|
|
| 425mg |
Extended Release |
Hard gelatin capsules, No. 0EL, white opaque cap with white opaque body, the cap is printed with “TWi TO87 425 ” in red ink, and body is printed with three red bands around 3/4 of the circumference of the body, containing white to off-white cylindrical-shaped microtablets. |
TWi TO87 425 |
 |
Bottle of 60 |
24979-087-04 |
|
|
|
BackTop